Dexamethasone reduction or omission with NEPA and olanzapine for HEC: A phase III trial.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7162510885
Cites:
Cited by:
Related to:
